Back
  1. Home
  2. Profile of Annalisa Tancredi (ULiège)
Profil

Tancredi Annalisa

See author's contact details
Main Referenced Co-authors
Reginster, Jean-Yves  (31)
Bruyère, Olivier  (10)
Richy, Florent (10)
Maassen, P. (9)
Pire, G. (8)
Main Referenced Keywords
ADAM (2); andropause (2); hypogonadism (2); testosterone (2); aging male (1);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège [BE] (1)
Main Referenced Disciplines
General & internal medicine (26)
Public health, health care sciences & services (26)
Endocrinology, metabolism & nutrition (6)
Rheumatology (2)
Biochemistry, biophysics & molecular biology (2)

Publications (total 36)

The most downloaded
491 downloads
Tancredi, A., Reginster, J.-Y., Schleich, F., Pire, G., Maassen, P., Luyckx, F., & Legros, J.-J. (September 2004). Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. European Journal of Endocrinology, 151 (3), 355-360. doi:10.1530/eje.0.1510355 https://hdl.handle.net/2268/26324

The most cited

89 citations (Scopus®)

Allouche, A., Nolens, G., Tancredi, A., Delacroix, L., Mardaga, J., Fridman, V., Winkler, R., Boniver, J., Delvenne, P., & Begon, D. (January 2008). The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors. Breast Cancer Research, 10 (1), 9. doi:10.1186/bcr1851 https://hdl.handle.net/2268/6304

Moons, P., Gosset, C., Beckers, J., Falez, F., Lucas, P., De Vliegher, K., Van Geert, M., Heyden, I., Chenot, M., & Tancredi, A. (2009). Intégration d’aides-soignants dans les soins infirmiers à domicile. (1240/UB/PPAS 2007).

Moons, P., Gosset, C., Beckers, J., Falez, F., Lucas, P., De Vliegher, K., Van Geert, M., Heyden, I., Chenot, M., & Tancredi, A. (2009). De integratie van zorgkundigen in de thuisverpleging. (1240/UB/PPAS 2007).

Leveque, A., Gosset, C., Guillaume, M., D'Hoore, W., Coppieters, Y., & Tancredi, A. (2008). Etude préparatoire à la mise en place d’un système d’information sanitaire en Communauté française et en Région wallonne, Rapport de recherche 2008.

Allouche, A., Nolens, G., Tancredi, A., Delacroix, L., Mardaga, J., Fridman, V., Winkler, R., Boniver, J., Delvenne, P., & Begon, D. (January 2008). The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors. Breast Cancer Research, 10 (1), 9. doi:10.1186/bcr1851
Peer Reviewed verified by ORBi

Tancredi, A., Legros, J.-J., Pire, G., Maassen, P., Luyckx, F., & Reginster, J.-Y. (September 2007). Analysis of the discriminant ability of shorter versions of the French ADAM questionnaire. Aging Male, 10 (3), 159-164. doi:10.1080/13685530701433121
Peer Reviewed verified by ORBi

Guillaume, M., Duquesne, P., Gillain, N., Husson, E., SEIDEL, L., Tancredi, A., & Albert, A. (2007). Evaluation du programme organisé de dépistage du cancer du sein chez les femmes âgées de 50 à 69 ans de la province de Luxembourg. Données 2002 à 2006. Marloie, Belgium: Département Prévention Santé.

Tancredi, A., Polet, A. S., Bosio-Le Goux, B., Augendre-Ferrante, B., & Reginster, J.-Y. (March 2006). Association between osteoporosis and cardiovascular risk factors in postmenopausal women. Osteoporosis International, 17 (Suppl.1), 84.
Peer Reviewed verified by ORBi

Manette, C., Collette, J., Sarlet, N., Tancredi, A., Zegels, B., & Reginster, J.-Y. (2006). Comprehensive therapy in osteoporosis using a single drug: From ADFR to strontium ranelate. Current Medicinal Chemistry, 13 (13), 1585-1590. doi:10.2174/092986706777442057
Peer Reviewed verified by ORBi

Tancredi, A., & Reginster, J.-Y. (2006). Osteoporosis and cardiovascular disease: in nonskeletal risk important in patients requiring an antiosteoporotic treatment? Future Rheumatology, 1, 481-491.
Peer Reviewed verified by ORBi

Tancredi, A., Reginster, J.-Y., Luyckx, F., & Legros, J.-J. (August 2005). No major month to month variation in free testosterone levels in aging mates. Minor impact on the biological diagnosis of 'andropause'. Psychoneuroendocrinology, 30 (7), 638-646. doi:10.1016/j.psyneuen.2005.02.002
Peer Reviewed verified by ORBi

Reginster, J.-Y., Richy, F., Rabenda, V., & Tancredi, A. (June 2005). Global prevalence and skeletal implications of vitamin D inadequacy. Annals of the Rheumatic Diseases, 64 (Suppl.III), 362.
Peer Reviewed verified by ORBi

Tancredi, A., Legros, J.-J., Pire, G., Maassen, P., LUYCKX, F., & Reginster, J.-Y. (March 2005). Analysis of the discriminant ability of shorter versions of the French ADAM questionnaire. Osteoporosis International, 16 (Suppl.3), 39.
Peer Reviewed verified by ORBi

Tancredi, A., Reginster, J.-Y., LUYCKX, F., & LEGROS, J.-J. (March 2005). No major month to month variations in free testosterone levels in aging males. Minor impact on the biological diagnosis of "andropause". Osteoporosis International, 16 (Suppl.3), 107.
Peer Reviewed verified by ORBi

Reginster, J.-Y., Richy, F., Rabenda, V., & Tancredi, A. (March 2005). Vitamin D inadequacy: global prevalence and skeletal implications. Osteoporosis International, 16 (Suppl.3), 64.
Peer Reviewed verified by ORBi

Tancredi, A., Bosio-Le goux, B., Augendre-Ferrante, B., & Reginster, J.-Y. (March 2005). Osteoporosis in daily clinical practice: prevalence of acute predictors in French postmenopausal women. Osteoporosis International, 16 (Suppl.3), 108-109.
Peer Reviewed verified by ORBi

Tancredi, A., Bosio-Le Goux, B., Augendre-Ferrante, B., & Reginster, J.-Y. (March 2005). Postmenopausal women initiating an antiosteoporotic treatment reported high prevalence of risk factors for cardiovascular diseases. Osteoporosis International, 16 (Suppl.3), 107.
Peer Reviewed verified by ORBi

Tancredi, A., Bosio-Le Goux, B., Augendre-Ferrante, B., & Reginster, J.-Y. (March 2005). Cross-sectional assessment of risk factors associated with breast cancer among French postmenopausal women being prescribed an antiosteoporotic treatment. Osteoporosis International, 16 (Suppl.3), 108.
Peer Reviewed verified by ORBi

Tancredi, A., Reginster, J.-Y., LUYCKX, F., & LEGROS, J.-J. (March 2005). Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. Osteoporosis International, 16 (Suppl.3), 107.
Peer Reviewed verified by ORBi

Tancredi, A., Bosio-Le Goux, B., Augendre-Ferrante, B., & Reginster, J.-Y. (March 2005). Management of osteoporosis after multi-risks assessment in French postmenopausal women. Osteoporosis International, 16 (Suppl.3), 108.
Peer Reviewed verified by ORBi

Tancredi, A., Reginster, J.-Y., Schleich, F., Pire, G., Maassen, P., Luyckx, F., & Legros, J.-J. (September 2004). Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. European Journal of Endocrinology, 151 (3), 355-360. doi:10.1530/eje.0.1510355
Peer Reviewed verified by ORBi

Hanssens, L. C., De Ceulaer, F., Tancredi, A., Bruyère, O., Richy, F., Halkin, V., Pire, G., Maassen, P., & Reginster, J.-Y. (May 2004). Evaluation of prevalence of osteoporosis and osteopenia in men presenting at multiple risk detection campaign. Osteoporosis International, 15 (Suppl.1), 54.
Peer Reviewed verified by ORBi

Hanssens, L., Tancredi, A., DeCeulaer, F., Bruyère, O., Zegels, B., Halkin, V., Pire, G., Maassen, P., & Reginster, J.-Y. (May 2004). Evaluation of the relationship between IGF-1, IGF-BP3, BMD and age in men presenting at a multiple risk detection campaign. Osteoporosis International, 15 (Suppl.1), 48-49.
Peer Reviewed verified by ORBi

Ethgen, O., Tancredi, A., Jacques, J., Bruyère, O., Richy, F., & Reginster, J.-Y. (May 2004). Do patients with osteoporotic hip fracture recover their initial health-related quality of life? Osteoporosis International, 15 (Suppl.1), 50.
Peer Reviewed verified by ORBi

DeCeulaer, F., Hanssens, L., Tancredi, A., Bruyère, O., Richy, F., Pire, G., Maassen, P., & Reginster, J.-Y. (May 2004). Evaluation of the osteoporosis self-assessment tool (OST) as a screening test for osteoporosis and osteopenia in men. Osteoporosis International, 15 (Suppl.1), 54.
Peer Reviewed verified by ORBi

De Ceulaer, F., Hanssens, L., Tancredi, A., Bruyère, O., Richy, F., Pire, G., Maassen, P., & Reginster, J.-Y. (November 2003). Evaluation of the osteoporosis self-assessment tool (OST) as a screening test for osteoporosis and osteopenia in men. Osteoporosis International, 14 (Suppl. 7), 93.
Peer Reviewed verified by ORBi

Hanssens, L., Tancredi, A., De Ceulaer, F., Bruyère, O., Zegels, B., Halkin, V., Pire, G., Maassen, P., & Reginster, J.-Y. (November 2003). Evaluation of the relationship between IGF-I, IGF-BP3, BMD and age in men presenting at a multiple risk detection campaign. Osteoporosis International, 14 (Suppl. 7), 90-S91.
Peer Reviewed verified by ORBi

Ethgen, O., Tancredi, A., Brugneaux, C., Richy, F., Bruyère, O., & Reginster, J.-Y. (November 2003). Prospective evaluation of health-related quality of life in total hip and knee arthroplasties. Osteoporosis International, 14 (Suppl. 7), 66.
Peer Reviewed verified by ORBi

Bosio Le Goux, B., Augendre-Ferrante, B., Tancredi, A., & Reginster, J.-Y. (November 2003). High prevalence of risk factors for cardiovascular diseases in postmenopausal women being prescribed an antiosteoporotic treatment. Osteoporosis International, 14 (Suppl. 7), 87.
Peer Reviewed verified by ORBi

Hanssens, L., De Ceulaer, F., Tancredi, A., Bruyère, O., Richy, F., Halkin, V., Pire, G., Maassen, P., & Reginster, J.-Y. (November 2003). Evaluation of prevalence of osteoporosis and osteopenia in men presenting at multiple risk detection campaign. Osteoporosis International, 14 (Suppl. 7), 90.
Peer Reviewed verified by ORBi

Tancredi, A., Bosio-Le Goux, B., & Reginster, J.-Y. (November 2003). Assessment of the risk of cardiovascular diseases in women with increased risk of osteoporosis. Osteoporosis International, 14 (Suppl. 7), 89.
Peer Reviewed verified by ORBi

Ethgen, O., Tancredi, A., Lejeune, E., Kvasz, A., Zegels, B., & Reginster, J.-Y. (November 2003). Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC index. Journal of Rheumatology, 30 (11), 2452-2459.
Peer Reviewed verified by ORBi

Bosio-Le Goux, B., Augendre-Ferrante, B., Tancredi, A., & Reginster, J.-Y. (November 2003). Assessment of osteoporosis in daily clinical practice. Osteoporosis International, 14 (Suppl. 7), 86.
Peer Reviewed verified by ORBi

Ethgen, O., Tancredi, A., Jacques, J., Bruyère, O., Richy, F., & Reginster, J.-Y. (November 2003). Do patient with osteoporotic hip fracture recover their initial health-related quality of life? Osteoporosis International, 14 (Suppl. 7), 66.
Peer Reviewed verified by ORBi

Reginster, J.-Y., Tancredi, A., & Rabenda, V. (2003). Glucosamine Sulphate in Osteoarthritis. Business Briefing : Long Term Healthcare Strategies, 57-60.

Ethgen, O., Tancredi, A., Lejeune, E., Zegels, B., Kvasz, A., & Reginster, J.-Y. (November 2002). A comparative analysis between the time trade-off and the willingness to pay approaches in hip and knee osteoarthritis. Osteoporosis International, 13 (Suppl. 3), 47.
Peer Reviewed verified by ORBi

Ethgen, O., Bruyère, O., Tancredi, A., Richy, F., De Ceulaer, F., & Reginster, J.-Y. (November 2002). Patient health profiles in osteoarthritis: is there a difference according to follow-up pattern? Results from the Belgian National Health Interview Survey. Osteoporosis International, 13 (Suppl.3), 49.
Peer Reviewed verified by ORBi

Contact ORBi